RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer
Hiroaki Ono(Saitama Medical University), Minoru Tanabe(Tokyo Institute of Technology)
Cited by 33
Related Papers
P300 inhibition enhances gemcitabine-induced apoptosis of pancreatic cancer
|Oncotarget|2016|65
PTK6 Promotes Cancer Migration and Invasion in Pancreatic Cancer Cells Dependent on ERK Signaling
|PLoS ONE|2014|44
C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer
|Scientific Reports|2021|41
Lysosomal membrane permeabilization causes secretion of IL-1β in human vascular smooth muscle cells
|Inflammation Research|2018|14